The document summarizes the Hybrid Assistive Limb (HAL) robotic exoskeleton suit developed by Tsukuba University and Cyberdyne to support and expand the physical capabilities of its users. There are two primary versions - HAL 3 provides leg function while HAL 5 is a full-body exoskeleton. Hospital trials of HAL 5 began in 2012 with tests continuing until 2014-2015. By 2012, over 130 medical institutions in Japan were using HAL suits. In 2013, HAL became the first powered exoskeleton to receive global safety certification and the first non-surgical medical treatment robot approved in Europe. In addition to medical uses, HAL has been used in construction and disaster